Back to 
TD Asset Management Inc.
TD Asset Management Inc.
NTLA
Showing 0 of 17 quarters
Position history for TD Asset Management Inc.'s holdings in Intellia Therapeutics, Inc.
No. TD Asset Management exited its NTLA (Intellia Therapeutics) position in Q2 2024. Its Q1 2024 13F listed 30,692 shares worth $844,337. TD Asset Management first reported NTLA in Q2 2020 and held it in 16 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of NTLA: ARK Investment Management LLC